RIVAR TEVA 10 MG

País: Israel

Língua: inglês

Origem: Ministry of Health

Ingredientes ativos:

RIVAROXABAN

Disponível em:

TEVA ISRAEL LTD

Código ATC:

B01AF01

Forma farmacêutica:

FILM COATED TABLETS

Composição:

RIVAROXABAN 10 MG

Via de administração:

PER OS

Tipo de prescrição:

Required

Fabricado por:

TEVA ISRAEL LTD, ISRAEL

Área terapêutica:

RIVAROXABAN

Indicações terapêuticas:

Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE)

Data de autorização:

2021-08-19

Folheto informativo - Bula

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s prescription only
Rivar Teva 10 mg
Film-coated tablets
Each film-coated tablet contains:
Rivaroxaban 10 mg
For information regarding inactive ingredients, see section 2 –
“Important
information about some of the ingredients of the medicine” and
section 6 – “Additional information”.
Read the entire leaflet carefully before using the medicine. This
leaflet
contains concise information about the medicine. If you have
additional
questions, refer to the doctor or the pharmacist.
In addition to the leaflet, there is a patient safety information card
for
Rivar Teva. This card contains important information that you must
know and act accordingly before starting treatment with Rivar Teva
and during the treatment.
Please review the patient safety information card and the patient
leaflet
before starting to use the preparation.
You should keep the leaflet and the card for further review, if
necessary.
This medicine has been prescribed for your treatment. Do not pass it
on to others. It may harm them even if it seems to you that their
medical
condition is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
Rivar Teva 10 mg is intended for:
• Prevention of the formation of blood clots in the veins, in adults
after an
elective hip or knee replacement surgery.
• Prevention of the recurrence of blood clots in the veins of the
legs (deep
vein thrombosis) and in pulmonary blood vessels (pulmonary embolism)
in adults, after having completed 6 months of treatment for deep vein
thrombosis or for a previous pulmonary embolism.
Therapeutic class: Rivar Teva 10 mg belongs to a class of medicines
called
anticoagulants, and acts by reducing the tendency to produce blood
clots
by blocking a factor involved in the clotting process (factor Xa).
2. BEFORE USING THE MEDICINE
Do not use this medicine if:
• You are sensitive (allergic) to rivaroxaban or to any of the other
ingredients the medicine cont